Long-range phasing of dynamic, tissue-specific and allele-specific regulatory elements.
Congratulations to Brad, who joined the Department of Cancer Biology at Dana-Farber as Chair on July 1, 2021. The Department of Cancer Biology performs lab-based research investigating the molecular pathways driving cancer. Under his leadership our 24 independent faculty and more than 300 laboratory personnel combine structural, chemical, genetic, computational, and biochemical approaches to identify molecular vulnerabilities unique … Continued
Brad delivers a seminar sponsored by the DF/HCC Connect:Science seminar series and the Leukemia & Lymphoma Society. In the midst of the Covid-19 pandemic, researchers continue to engage.
You can read the study in Nature
Brad was interviewed for the ACS Theory lab podcast last week! “Cancer has classically been thought of as a genetic disease, but…”